751 related articles for article (PubMed ID: 27804879)
1. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
2. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
4. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
Karamanidou T; Bourganis V; Kammona O; Kiparissides C
Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
[TBL] [Abstract][Full Text] [Related]
5. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
6. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
8. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
Suchaoin W; Bernkop-Schnürch A
Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
[TBL] [Abstract][Full Text] [Related]
12. Is nanotechnology a boon for oral drug delivery?
Agrawal U; Sharma R; Gupta M; Vyas SP
Drug Discov Today; 2014 Oct; 19(10):1530-46. PubMed ID: 24786464
[TBL] [Abstract][Full Text] [Related]
13. Solid Lipid-Polymer Hybrid Nanoparticles by In Situ Conjugation for Oral Delivery of Astaxanthin.
Wang T; Hu Q; Lee JY; Luo Y
J Agric Food Chem; 2018 Sep; 66(36):9473-9480. PubMed ID: 30130387
[TBL] [Abstract][Full Text] [Related]
14. Oral nanomedicine approaches for the treatment of psychiatric illnesses.
Dening TJ; Rao S; Thomas N; Prestidge CA
J Control Release; 2016 Feb; 223():137-156. PubMed ID: 26739547
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
Das S; Chaudhury A
AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.
Shadab M; Haque S; Sheshala R; Meng LW; Meka VS; Ali J
Curr Pharm Des; 2017; 23(3):440-453. PubMed ID: 27784250
[TBL] [Abstract][Full Text] [Related]
18. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?
Diab R; Jaafar-Maalej C; Fessi H; Maincent P
AAPS J; 2012 Dec; 14(4):688-702. PubMed ID: 22767270
[TBL] [Abstract][Full Text] [Related]
19. Paliperidone-Loaded Nanolipomer System for Sustained Delivery and Enhanced Intestinal Permeation: Superiority to Polymeric and Solid Lipid Nanoparticles.
Helal HM; Mortada SM; Sallam MA
AAPS PharmSciTech; 2017 Aug; 18(6):1946-1959. PubMed ID: 27914041
[TBL] [Abstract][Full Text] [Related]
20. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
Rao S; Prestidge CA
Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
